Cargando…

Minimal Risk of Drug-Induced Liver Injury With Molnupiravir and Ritonavir-Boosted Nirmatrelvir

Detalles Bibliográficos
Autores principales: Wong, Grace Lai-Hung, Hui, Vicki Wing-Ki, Yip, Terry Cheuk-Fung, Lui, Grace Chung-Yan, Hui, David Shu-Cheong, Wong, Vincent Wai-Sun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: by the AGA Institute. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9568277/
https://www.ncbi.nlm.nih.gov/pubmed/36126688
http://dx.doi.org/10.1053/j.gastro.2022.09.008
_version_ 1784809608492089344
author Wong, Grace Lai-Hung
Hui, Vicki Wing-Ki
Yip, Terry Cheuk-Fung
Lui, Grace Chung-Yan
Hui, David Shu-Cheong
Wong, Vincent Wai-Sun
author_facet Wong, Grace Lai-Hung
Hui, Vicki Wing-Ki
Yip, Terry Cheuk-Fung
Lui, Grace Chung-Yan
Hui, David Shu-Cheong
Wong, Vincent Wai-Sun
author_sort Wong, Grace Lai-Hung
collection PubMed
description
format Online
Article
Text
id pubmed-9568277
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher by the AGA Institute.
record_format MEDLINE/PubMed
spelling pubmed-95682772022-10-16 Minimal Risk of Drug-Induced Liver Injury With Molnupiravir and Ritonavir-Boosted Nirmatrelvir Wong, Grace Lai-Hung Hui, Vicki Wing-Ki Yip, Terry Cheuk-Fung Lui, Grace Chung-Yan Hui, David Shu-Cheong Wong, Vincent Wai-Sun Gastroenterology Research Letter by the AGA Institute. 2023-01 2022-09-17 /pmc/articles/PMC9568277/ /pubmed/36126688 http://dx.doi.org/10.1053/j.gastro.2022.09.008 Text en © 2023 by the AGA Institute. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Research Letter
Wong, Grace Lai-Hung
Hui, Vicki Wing-Ki
Yip, Terry Cheuk-Fung
Lui, Grace Chung-Yan
Hui, David Shu-Cheong
Wong, Vincent Wai-Sun
Minimal Risk of Drug-Induced Liver Injury With Molnupiravir and Ritonavir-Boosted Nirmatrelvir
title Minimal Risk of Drug-Induced Liver Injury With Molnupiravir and Ritonavir-Boosted Nirmatrelvir
title_full Minimal Risk of Drug-Induced Liver Injury With Molnupiravir and Ritonavir-Boosted Nirmatrelvir
title_fullStr Minimal Risk of Drug-Induced Liver Injury With Molnupiravir and Ritonavir-Boosted Nirmatrelvir
title_full_unstemmed Minimal Risk of Drug-Induced Liver Injury With Molnupiravir and Ritonavir-Boosted Nirmatrelvir
title_short Minimal Risk of Drug-Induced Liver Injury With Molnupiravir and Ritonavir-Boosted Nirmatrelvir
title_sort minimal risk of drug-induced liver injury with molnupiravir and ritonavir-boosted nirmatrelvir
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9568277/
https://www.ncbi.nlm.nih.gov/pubmed/36126688
http://dx.doi.org/10.1053/j.gastro.2022.09.008
work_keys_str_mv AT wonggracelaihung minimalriskofdruginducedliverinjurywithmolnupiravirandritonavirboostednirmatrelvir
AT huivickiwingki minimalriskofdruginducedliverinjurywithmolnupiravirandritonavirboostednirmatrelvir
AT yipterrycheukfung minimalriskofdruginducedliverinjurywithmolnupiravirandritonavirboostednirmatrelvir
AT luigracechungyan minimalriskofdruginducedliverinjurywithmolnupiravirandritonavirboostednirmatrelvir
AT huidavidshucheong minimalriskofdruginducedliverinjurywithmolnupiravirandritonavirboostednirmatrelvir
AT wongvincentwaisun minimalriskofdruginducedliverinjurywithmolnupiravirandritonavirboostednirmatrelvir